Alcon Inc.

History

Year	Detail
1945	Robert Alexander and William Conner founded Alcon.
1947	Alcon Laboratories Inc. was incorporated.
1950	The company launched its first two ophthalmic products, Ophthalzin and Zincfrin.
1962	The Alcon Trust is currently known as Alcon Foundation.
1969	Alcon's surgical division is formed with seven associated.
1971	Alcon goes public with a listing on the New York Stock Exchange.
1989	Launched NewVue.
2003	Alcon launched SYSTANE.
2007	Alcon acquired WaveLight AG.
2010	Alcon acquired LenSx Lasers Inc.
2011	Alcon and CIBA VISION merged.
2019	Alcon became an independent publicly traded company after spinning off from Novartis.
2021	Alcon acquires Simbrinza.
2022	Alcon acquired Ivantis and further introduced the Fidelis Virtual Reality Ophthalmic Surgical Simulator.
2023	Alcon expanded the partnership with Plastic Bank.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment